Clinical trial
Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma
NCT00004148 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00004148 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma |
| Official title | A Phase I Trial of Intra Lesional RV-B7.1 Vaccine in the Treatment of Malignant Melanoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological |
| Interventions | recombinant vaccinia-B7.1 vaccine |
| Enrollment | 12 |
| Start date | Oct 1, 1999 |
| Primary completion | Apr 1, 2006 |
| First posted | Feb 20, 2004 |
| Last update posted | Feb 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: